During the COVID-19 pandemic, as many stayed home, direct-to-consumer prescription drug advertising—already big business—boomed. Websites, social media, streaming services, and other on-demand platforms became ideal real estate for drug manufacturers, start up clinics, telemedicine practitioners, and others to market drugs, whether they were FDA-approved or not.